Economic evaluation in rheumatology: a necessity for clinical studies.
作者： B Griffiths , P Emery , R Akehurst
关键词: Intensive care medicine 、 Economic evaluation 、 Medicine 、 Surgery 、 Cost–benefit analysis 、 Internal medicine 、 Treatment outcome 、 Rheumatology 、 Alternative medicine
摘要:
core.ac.uk
sci-hub.se 参考文章(10)
Judith D. Bentkover, Andrew M. Baker, Herbert Kaplan, Nabumetone in elderly patients with osteoarthritis: economic benefits versus ibuprofen alone or ibuprofen plus misoprostol. PharmacoEconomics. ,vol. 5, pp. 335- 342 ,(1994) , 10.2165/00019053-199405040-00007
J. McEwen, S. P. McKenna, S. M. Hunt, Measuring health status: a new tool for clinicians and epidemiologists The Journal of the Royal College of General Practitioners. ,vol. 35, pp. 185- 188 ,(1985)
James F. Fries, Patricia Spitz, R. Guy Kraines, Halsted R. Holman, Measurement of patient outcome in arthritis Arthritis & Rheumatism. ,vol. 23, pp. 137- 145 ,(1980) , 10.1002/ART.1780230202
C Jenkinson, A Coulter, L Wright, Short form 36 (SF36) health survey questionnaire: normative data for adults of working age. BMJ. ,vol. 306, pp. 1437- 1440 ,(1993) , 10.1136/BMJ.306.6890.1437
P. Emery, M. Salmon, H. Bradley, P. Wordsworth, E. Tunn, P. A. Bacon, R. Waring, Genetically determined factors as predictors of radiological change in patients with early symmetrical arthritis. BMJ. ,vol. 305, pp. 1387- 1389 ,(1992) , 10.1136/BMJ.305.6866.1387
Andrew Gough, Jeff Faint, Mike Salmon, Andrew Hassell, Paul Wordsworth, Darrell Pilling, Andrew Birley, Paul Emery, Genetic typing of patients with inflammatory arthritis at presentation can be used to predict outcome. Arthritis & Rheumatism. ,vol. 37, pp. 1166- 1170 ,(1994) , 10.1002/ART.1780370809
Jonathan T Edelson, Anna NA Tosteson, Paul Sax, None, Cost-effectiveness of Misoprostol for Prophylaxis Against Nonsteroidal Anti-inflammatory Drug—Induced Gastrointestinal Tract Bleeding JAMA: The Journal of the American Medical Association. ,vol. 264, pp. 41- 47 ,(1990) , 10.1001/JAMA.1990.03450010045028
A Szczepura, Finding a way through the cost and benefit maze BMJ. ,vol. 309, pp. 1314- 1315 ,(1994) , 10.1136/BMJ.309.6965.1314
M S Thompson, Willingness to pay and accept risks to cure chronic disease. American Journal of Public Health. ,vol. 76, pp. 392- 396 ,(1986) , 10.2105/AJPH.76.4.392
A. J. G. Dickens, The European Commission and Health Care Rheumatology. ,vol. 32, pp. 28- 30 ,(1993) , 10.1093/RHEUMATOLOGY/32.SUPPL_4.28